Back to search

Article

Relationship between subtype-specific minimal residual disease level and long-term prognosis in children with acute lymphoblastic leukemia

2024-01-03

Abstract excerpt

In childhood acute lymphoblastic leukemia (ALL), minimal residual disease (MRD) risk stratification criteria specific to common genetic subtypes are unclear. Among 723 children with newly diagnosed ALL treated with the Chinese Children Leukemia Group trial CCLG-2008 protocol, at time point 1 (TP1, the end of induction) and TP2 (before consolidation for standard risk and intermediate risk group, or before the secon...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7376acfd-7be2-5156-9fde-5d9235efc9bb
DOI
10.21203/rs.3.rs-3810073/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Relationship between subtype-specific minimal residual disease level and long-term prognosis in children with acute lymphoblastic leukemiaDOI 10.21203/rs.3.rs-3810073/v1
Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia.Semantic proximity
[Effects of minimal residual disease level on day 33 of remission induction and IKZF1 genotype on the survival of children with B-lineage acute lymphoblastic leukemia].Semantic proximity
Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease–Directed TherapySemantic proximity
Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - A multi-centric clinical study of GD-2008-ALL protocolSemantic proximity
Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia.Semantic proximity
Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study GroupSemantic proximity
Significance of minimal residual disease in pediatric mixed phenotype acute leukemia: a multicenter cohort study.Semantic proximity
Key Markers of Minimal Residual Disease in Childhood Acute Lymphoblastic LeukemiaSemantic proximity
Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia.Semantic proximity
Prognostic significance of NOTCH1/FBXW7 mutations in pediatric T cell acute lymphoblastic leukemia: a study of minimal residual disease risk-directed CCLG-ALL 2008 treatment protocol.Semantic proximity
Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials.Semantic proximity
Prognostic Implication of Early Minimal Residual Disease Evaluation in Patients with Chronic Myelomonocytic LeukemiaSemantic proximity
Select a neighboring publication to make it the new centre.